The next-generation sequencing (NGS) data analysis market is projected to reach $4.21b by 2032 at a compound annual growth rate of approximately 20%, according to SNS Insider pvt ltd.

Appistry is a scientific software company that bridges the gap between genomics data and health outcomes by making next-generation sequencing data analysis more approachable and actionable to ...

An overview of bioinformatics and where it fits into NGS workflows–including target enrichment; A walk-through of the analysis stages of Roche’s bioinformatics container solution for target-enriched ...

Bionano Announces Upgrades to its Software and Compute Platforms to Make Analysis of OGM, Microarray and NGS Data Easier, Faster and More Accurate ...

But, as with any great methodology shift, several challenges impede its widespread implementation. From cancer complexities such as tumor heterogeneity to bottlenecks in next-generation sequencing ...

Collaboration integrates DNAnexus’ proven biomedical data analysis platform with Twist’s NGS Methylation Detection and Unique Molecular Identifier Adapter Systems MOUNTAIN VIEW, Calif. & SOUTH ...

Next-generation sequencing (NGS) has revolutionized oncology diagnostics. However, the interpretation of complex genomic data has become a critical bottleneck in clinical workflows. Manual data ...

In this episode, supported by Zymo Research (CA, USA), guest host Georgia Bickerton explores next-generation sequencing (NGS) data and how bioinformatic pipelines and workflows can be optimized to ...